FDA
-
-
-
-
-
-
-
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
-
-
-
-
-
-
-
Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Theralase(R) Releases 2024 Annual Financial Statements
-
-
-
-
-
-
-
Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug
-
-
-
-
-
-
-
Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Theralase Releases Q322 Interim Financial Statements
-
-
-
-
-
-
-
Theralase Release FY2020 Audited Financial Statements
-
334,882 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


